Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
RESEARCH TRIANGLE PARK, N.C., Sept. 12, 2011 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that Niels Ejskjaer, M.D., Ph.D., Department of Endocrinology M, Aarhus University...
-
RESEARCH TRIANGLE PARK, N.C., Sept. 7, 2011 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq: TZYM), today announced that Vipin Garg, President and CEO and Richard Eisenstadt, CFO will present at the...
-
RESEARCH TRIANGLE PARK, N.C., Aug. 25, 2011 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM) today announced that Gordana Kosutic, M.D. has resigned as Vice President, Clinical and Regulatory...
-
RESEARCH TRIANGLE PARK, N.C., Aug. 18, 2011 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM) today announced that Brent Bankosky has joined the Company as Vice President, Business Development. In his...
-
RESEARCH TRIANGLE PARK, N.C., Aug. 11, 2011 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), a clinical stage biopharmaceutical company focused on discovering, developing and commercializing novel,...
-
RESEARCH TRIANGLE PARK, N.C., Aug. 9, 2011 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that David Moore has joined the Company as Vice President, Commercial Operations, a newly...
-
RESEARCH TRIANGLE PARK, N.C., Aug. 2, 2011 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that it will report second quarter 2011 financial results after the close of the market on...
-
RESEARCH TRIANGLE PARK, N.C., July 28, 2011 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), a late-stage biopharmaceutical company, today announced that Vipin Garg, President and CEO, and Richard...
-
RESEARCH TRIANGLE PARK, N.C., July 20, 2011 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM) today announced that its Chief Financial Officer, Richard Eisenstadt, has been honored as a Triangle...
-
RESEARCH TRIANGLE PARK, N.C., May 12, 2011 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), a clinical‑stage biopharmaceutical company focused on discovering, developing and commercializing...